United States, Mexico and Bolivia lose measles elimination status after sustained transmission
Solo los hechos

United States, Mexico and Bolivia lose measles elimination status after sustained transmission

Resumen

The Pan American Health Organisation said the United States, Mexico and Bolivia have lost their measles elimination status after the virus circulated locally for more than a year, marking a setback for the region’s disease-control efforts.

The Pan American Health Organisation announced on 17 November that the United States, Mexico and Bolivia have lost their measles elimination status after the virus was found to be circulating continuously for at least 12 months in each country. The regional Measles and Rubella Elimination Monitoring and Re-Verification Commission reviewed epidemiological and laboratory data from all 47 reporting countries and territories of the Americas at its sixth annual meeting held 10-13 November and concluded that endemic transmission had been re-established.

In the United States, the outbreak began on 20 January 2025 and reached the 12-month threshold on 20 January 2026. The loss follows a period in which the Americas regained measles elimination status in 2024 after interrupting endemic transmission in Venezuela and Brazil, but then saw a regional setback in November 2025 after sustained transmission in Canada.

The commission reported that the region has recorded 58,213 confirmed measles cases and 82 deaths as of 13 November, compared with 12,806 cases during the same period in the previous year. Health officials emphasize that achieving and maintaining at least 95 % coverage with both doses of the measles vaccine, supported by strong surveillance and rapid outbreak response, is essential to restore elimination.

"The re-establishment of endemic measles transmission in the United States, Mexico and Bolivia underscores the need for intensified vaccination efforts and coordinated public-health action across the region," a PAHO spokesperson said.

The report also highlighted broader factors driving global increases in measles cases, including gaps in routine two-dose coverage, disruptions caused by the COVID-19 pandemic, vaccine misinformation, and challenges such as poverty, geographic isolation and weak health infrastructure. Experts note that the measles vaccine remains about 97 % effective in preventing severe illness and death, and that vaccination programmes have averted more than 60 million deaths worldwide between 2000 and 2023.

Sigue leyendo, gratis

Crea una cuenta gratis para seguir las noticias. No se requiere tarjeta.